Health News Roundup: Moderna CEO to testify in senate on proposed vaccine price hike; WHO maintains public health emergency alert for mpox and more
In January, Sanders had written to Bancel to refrain from quadrupling the price of COVID-19 vaccine, after Moderna said it was considering pricing its vaccine at $110 to $130 per dose in the United States, when it shifts from government contracting to commercial distribution. U.S. FDA panel backs OTC opioid overdose drug, proposes label changes Emergent BioSolutions Inc's over-the-counter version of opioid overdose reversing drug received unanimous support from U.S. Food and Drug Administration's panel of advisers, sending shares of the contract drugmaker up nearly 16% after market.
Source: devdiscourse.com
